Skip to main content
SpringerLink
Log in

Ipilimumab — una nuova terapia immunomodulante che causa ipofisite autoimmune: descrizione di un caso e revisione della letteratura

Ipilimumab — a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review

  • Novità in Endocrinologia
  • Published:
L’Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. S.C. di Endocrinologia, Ospedale Niguarda, Milano, Italia

    Renato Cozzi

Authors
  1. A. Juszczak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Karavitaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. R. Middleton
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. B. Grossman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Renato Cozzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Juszczak, A., Gupta, A., Karavitaki, N. et al. Ipilimumab — una nuova terapia immunomodulante che causa ipofisite autoimmune: descrizione di un caso e revisione della letteratura. L’Endocrinologo 13, 143 (2012). https://doi.org/10.1007/BF03345971

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345971

Search

Navigation